A Study to Evaluate Safety and Efficacy of OLX72021 in Healthy Males With Androgenetic Alopecia

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Androgenetic Alopecia (AGA)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Emeritus Research Camberwell, Camberwell, Victoria, Australia
Contact: Study coordinator (Rafik Malik, MBBS) · info@emeritusresearch.com · +613 9509 6166

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study of EPI-001 in Patients With Androgenetic Alopecia

Androgenetic Alopecia

Abroad (travel likely)RecruitingPHASE1, PHASE2

Seoul, South Korea

Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia

Androgenetic Alopecia (AGA) · Healthy Volunteers - Male and Female

Abroad (travel likely)RecruitingPHASE1, PHASE2

Sydney, Australia · Brisbane, Australia

Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia

Androgenetic Alopecia · Female Pattern Baldness

Abroad (travel likely)RecruitingPHASE3

Bad Bentheim, Germany · Berlin, Germany

Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia

Androgenetic Alopecia

Abroad (travel likely)RecruitingPHASE3

Beijing, China